Makoto Handa Selected Research

ACT regimen

8/2021

Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Handa Research Topics

Disease

8	Thrombocytopenia (Thrombopenia) 01/2017 - 06/2003
8	Thrombosis (Thrombus) 03/2011 - 12/2003
7	Neoplasms (Cancer) 01/2022 - 07/2019
7	Hemorrhage 01/2016 - 07/2007
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
1	Body Weight (Weight, Body) 01/2022
1	Paralysis (Palsy) 01/2022
1	Melanoma (Melanoma, Malignant) 08/2021
1	Fever (Fevers) 08/2021
1	Leukopenia 08/2021
1	Paraplegia (Spastic Paraplegia) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Back Pain (Backache) 09/2020
1	Cerebral Palsy (Spastic Diplegia) 06/2020
1	Spinal Cord Diseases 06/2020
1	Giant Cell Tumors (Giant Cell Tumor) 07/2019
1	Giant Cell Tumor of Bone 07/2019
1	Shock 01/2016
1	Lung Injury 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 02/2015
1	Erythema Infectiosum (Fifth Disease) 01/2011
1	Vascular System Injuries 04/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2006
1	Aplastic Anemia (Anemia, Hypoplastic) 12/2006
1	Hemolytic Anemia 06/2003
1	Thrombotic Thrombocytopenic Purpura 06/2003
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 06/2003

Drug/Important Bio-Agent (IBA)

6	Fibrinogen (Factor I)FDA Link 01/2016 - 07/2007
6	Liposomes (Liposome)IBA 01/2016 - 04/2010
5	CollagenIBA 03/2011 - 12/2003
4	Adenosine Diphosphate (ADP)IBA 09/2015 - 08/2013
3	Peptides (Polypeptides)IBA 01/2016 - 02/2015
2	Immune Checkpoint InhibitorsIBA 08/2021 - 02/2021
2	Adenosine (Adenocard)FDA LinkGeneric 01/2016 - 02/2015
2	Phosphates (Orthophosphate)IBA 01/2016 - 02/2015
2	Diphosphates (Pyrophosphates)IBA 01/2016 - 02/2015
2	Immunoglobulin M (IgM)IBA 09/2015 - 01/2011
2	Pharmaceutical PreparationsIBA 09/2015 - 10/2013
2	Hemostatics (Antihemorrhagics)IBA 02/2015 - 04/2010
2	von Willebrand FactorIBA 03/2011 - 02/2005
2	fibrinopeptides gammaIBA 04/2010 - 07/2007
2	Platelet Membrane GlycoproteinsIBA 02/2005 - 06/2003
1	ChemokinesIBA 08/2021
1	CateninsIBA 08/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021
1	InterferonsIBA 02/2021
1	NitrogenIBA 02/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021
1	TESIBA 09/2020
1	Denosumab FDA Link 07/2019
1	ethyl palmitateIBA 01/2017
1	Busulfan (Busulfex)FDA Link 01/2017
1	ZM 241385 (ZM241385)IBA 01/2016
1	Purinergic P1 Receptor AntagonistsIBA 01/2016
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2016
1	1-propyl-8-(4-sulfophenyl)xanthineIBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2016
1	Adenosine A2B ReceptorIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	Amino Acids FDA Link 02/2015
1	Glycoproteins (Glycoprotein)IBA 08/2013
1	LigandsIBA 03/2011
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 03/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2011
1	RistocetinIBA 03/2011
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 03/2011
1	Tirofiban (Aggrastat)FDA Link 03/2011
1	Phosphodiesterase 3 InhibitorsIBA 03/2011
1	Viral DNAIBA 01/2011
1	Iopamidol (Isovue)FDA LinkGeneric 04/2010
1	Coloring Agents (Dyes)IBA 04/2010
1	Indicators and Reagents (Reagents)IBA 07/2005
1	thiamine triphosphorate (TTP)IBA 06/2003
1	ADAMTS13 ProteinIBA 06/2003
1	Protein Sorting Signals (Signal Peptide)IBA 06/2003

Therapy/Procedure

4	Therapeutics 08/2021 - 06/2003
2	Aftercare (After-Treatment) 01/2017 - 01/2016
2	Blood Transfusion (Blood Transfusions) 08/2009 - 01/2009
2	Microspheres (Microsphere) 01/2006 - 12/2003
1	Operative Time 01/2022
1	Bed Rest (Bedrest) 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	ACT regimen 08/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2021
1	Radiotherapy 01/2021
1	Laminectomy 10/2020
1	Reoperation 09/2020
1	Laminoplasty 06/2020
1	Pedicle Screws 06/2020
1	Lasers (Laser) 01/2016
1	Erythrocyte Transfusion 11/2015
1	Injections 09/2015
1	Operative Blood Salvage 01/2009
1	Drug Therapy (Chemotherapy) 12/2006
1	Hematopoietic Stem Cell Transplantation 12/2006
1	Platelet Transfusion (Blood Platelet Transfusions) 07/2005
1	Plasma Exchange 06/2003